Conformers of a novel lipopeptide antibiotic, Kannurin inhibits SARS-Cov2 replication via interfering with RNA-dependent-RNA polymerase activation and function. - H. Shabeer Ali; P. Prajosh; K. Sreejith; M. Divya Lakshmanan (Int. J. Comput. Biol. Drug Des., 2021)